All lobbying filings

FARRAGUT PARTNERS LLP

Lobbying for GENENTECH · Biotechnology

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 7

JEFFERY C. MORTIER

Previously held: Prof Staff on E&C Cmte, LA Rep Whitfield and Intern Devin Nunes
JEFF MACKINNON

Previously held: LD & LA Rep. Joe Barton (RTexas)
SARAH WALTER

Previously held: Former Legislative Director/Chief Counsel, Sen. John Breaux
EDWARD WHITFIELD

Previously held: U.S. Representatives (21 yrs.)
KRISTEN BAUTZ

Previously held: Senior Advisor and Special Projects Coordinator, Rep Wasserman Shultz
DYLAN MOORE

Previously held: Intern/Staff Assistant, Speaker John Boehner (OH-8); Legislative Assistant/Legislative Director/Deputy Chief of Staff, Rep. Larry Bucshon (IN-8); Intern, Rep. Mike Turner (OH-10)
CONSTANTINE HINGSON

Previously held: Chief of Staff, Senator Dan Coats; Counsel/Legislative Director, Senator Judd Gregg; General Counsel, Senator Elizabeth Dole

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 4299
Protecting Patient Access to Cancer and Complex Therapies Act

Lobbying activity 1

Health Issues

Issues related to legislation relating to the 340B drug discount program. Also, legislation relating to Medicare physician payments, including H.R. 4299. Issues relating to GLOBE/GUARD

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.